Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02730429
Recruitment Status : Active, not recruiting
First Posted : April 6, 2016
Last Update Posted : November 22, 2019
Sponsor:
Collaborators:
European Network of Gynaecological Oncological Trial Groups (ENGOT)
Gynecologic Cancer Intergroup (GCIG)
North Eastern German Society of Gynaecological Oncology
Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO)
Grupo Español de Investigación en Cáncer de Ovario
Information provided by (Responsible Party):
Nordic Society of Gynaecological Oncology - Clinical Trials Unit

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 15, 2018
Estimated Study Completion Date : December 2022